疤痕子宫再次妊娠的产妇进行阴道试产及剖宫产的临床效果观察

Clinical effect of vaginal delivery and cesarean section in women with scar uterus pregnancy

目的探讨疤痕子宫再次妊娠的产妇进行阴道试产及剖宫产的临床效果。方法收2016年1月-2016年12月间选择于本院进行分娩者共5690例,其中疤痕子宫试产总数为196例,将其作为此次研究对象设置为观察组,同期选取196例健康初产妇设置为对照组,根据两组产妇的实际情况选择合理的分娩方式,对比两组产妇分娩结局及分娩相关指标、并发症等情况。结果本次调查发现观察组接受阴道试产者共有144例,其中中转剖宫产率为15.28%,阴道分娩成功率为84.72%,对照组阴道试产者150例,阴道分娩成功率为100%,组间差异具有统计学意义,P<0.05;两组经阴道试产的产妇在产程时间、产时出血、新生儿Apgar评分以及住院时间等方面资料差异对比无统计学意义,P>0.05;而经剖宫产分娩的观察组产妇,其手术时间、住院时间明显长于对照组,产后出血明显少于对照组,组间差异对比具有统计学意义,P<0.05;两组产妇分娩期间并发症发生率对比均无统计学意义,P<0.05。结论疤痕子宫再次妊娠产妇阴道试产成功率高,且妊娠结局与健康初产妇相近,具有良好的提高生育质量作用,值得在临床应用中推广。

Objective To discuss on the vaginal trial-delivery and cesarean section conditions for scarred uterus patients with repeated pregnancy. Method 5690 delivery persons delivered from January 2016 to December 2016 in our hospital were selected. 196 patients with scarred uterus were selected as the observation group;196 healthy primipara were selected as the control group. According to their conditions, the reasonable delivery modes were applied. The delivery outcomes, related index and complications were observed.Result For the observation group, there were 144 vaginal delivery cases;the rate of Cesarean section rate was 15.28% while the vaginal delivery rate was 84.72%. For the control group, there were 150 vaginal delivery cases;the vaginal delivery rate was 100%(P>0.05);the labor time. intrapartum hemorrhage volume, Apgar points and hospitalization time for two groups were not significantly different(P>0.05);the operation time and hospitalization time for observation group was longer than that of the control group;the postpartum bleeding volume for observation group was fewer than that of the control group(P >0.05);the incidence rate of complications for two groups was not significantly different(P>0.05). Conclusion For scarred uterus patients with repeated pregnancy, the vaginal trial-delivery rate is high;the delivery outcomes for scarred uterus puerpera and healthy primipara are much close which has good effect on improving reproductive quality, and it is worth popularizing in clinical application.